M. Simonelli

REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma

C. Dealis, M. Caccese, C. Caserta, 2024, ESMO open.